Choplin NT - Search Results

1

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.

Schuman JS, Horwitz B, Choplin NT, David R, Albracht D, Chen K. Schuman JS, et al. Among authors: choplin nt. Arch Ophthalmol. 1997 Jul;115(7):847-52. doi: 10.1001/archopht.1997.01100160017002. Arch Ophthalmol. 1997. PMID: 9230823 Clinical Trial.

2

Brimonidine tartrate: a one-month dose response study.

Derick RJ, Robin AL, Walters TR, Barnebey HS, Choplin N, Schuman J, Kelley EP, Chen K, Stoecker JF. Derick RJ, et al. Ophthalmology. 1997 Jan;104(1):131-6. doi: 10.1016/s0161-6420(97)30349-2. Ophthalmology. 1997. PMID: 9022117 Clinical Trial.

3

Initial clinical experience with the Ahmed Glaucoma Valve implant.

Coleman AL, Hill R, Wilson MR, Choplin N, Kotas-Neumann R, Tam M, Bacharach J, Panek WC. Coleman AL, et al. Am J Ophthalmol. 1995 Jul;120(1):23-31. doi: 10.1016/s0002-9394(14)73755-9. Am J Ophthalmol. 1995. PMID: 7611326 Clinical Trial.

4

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group. Noecker RS, et al. Among authors: choplin nt. Am J Ophthalmol. 2003 Jan;135(1):55-63. doi: 10.1016/s0002-9394(02)01827-5. Am J Ophthalmol. 2003. PMID: 12504698 Clinical Trial.

5

Follow-up of the original cohort with the Ahmed glaucoma valve implant.

Topouzis F, Coleman AL, Choplin N, Bethlem MM, Hill R, Yu F, Panek WC, Wilson MR. Topouzis F, et al. Am J Ophthalmol. 1999 Aug;128(2):198-204. doi: 10.1016/s0002-9394(99)00080-x. Am J Ophthalmol. 1999. PMID: 10458176 Clinical Trial.

6

Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.

Silverstone D, Zimmerman T, Choplin N, Mundorf T, Rose A, Stoecker J, Kelley E, Lue J. Silverstone D, et al. Am J Ophthalmol. 1991 Jul 15;112(1):56-60. doi: 10.1016/s0002-9394(14)76213-0. Am J Ophthalmol. 1991. PMID: 1882923 Clinical Trial.

7

A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.

Choplin N, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group. Choplin N, et al. Surv Ophthalmol. 2004 Mar;49 Suppl 1:S19-25. doi: 10.1016/j.survophthal.2003.12.016. Surv Ophthalmol. 2004. PMID: 15016558 Clinical Trial.

8

Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma).

Choplin NT. Choplin NT. Arch Ophthalmol. 1989 Feb;107(2):167-8. doi: 10.1001/archopht.1989.01070010173007. Arch Ophthalmol. 1989. PMID: 2916963 No abstract available.

9

Differentiating patients with glaucoma from glaucoma suspects and normal subjects by nerve fiber layer assessment with scanning laser polarimetry.

Choplin NT, Lundy DC, Dreher AW. Choplin NT, et al. Ophthalmology. 1998 Nov;105(11):2068-76. doi: 10.1016/S0161-6420(98)91127-7. Ophthalmology. 1998. PMID: 9818608

10

The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting.

Choplin NT, Lundy DC. Choplin NT, et al. Ophthalmology. 2001 May;108(5):899-904. doi: 10.1016/s0161-6420(00)00652-7. Ophthalmology. 2001. PMID: 11320020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters